Takeo Endo

690 total citations
24 papers, 405 citations indexed

About

Takeo Endo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Takeo Endo has authored 24 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Surgery. Recurrent topics in Takeo Endo's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Takeo Endo is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Takeo Endo collaborates with scholars based in Japan, Myanmar and China. Takeo Endo's co-authors include Hiroaki Satoh, Atsuhisa Tamura, Yoshio Okano, Masahiko Ando, Tomoya Kawaguchi, Yoshifumi Soejima, Minoru Takada, Hidenori Ibata, Michihiro Yoshimi and Mitsuhiro Kamimura and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Eating Disorders and Journal of Thoracic Oncology.

In The Last Decade

Takeo Endo

20 papers receiving 398 citations

Peers

Takeo Endo
Takeo Endo
Citations per year, relative to Takeo Endo Takeo Endo (= 1×) peers Kyoichi Kihara

Countries citing papers authored by Takeo Endo

Since Specialization
Citations

This map shows the geographic impact of Takeo Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Endo more than expected).

Fields of papers citing papers by Takeo Endo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Endo. The network helps show where Takeo Endo may publish in the future.

Co-authorship network of co-authors of Takeo Endo

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Endo. A scholar is included among the top collaborators of Takeo Endo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Endo. Takeo Endo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ano, Satoshi, Norihiro Kikuchi, Toshihiro Shiozawa, et al.. (2024). Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer. Anticancer Research. 44(6). 2725–2730. 2 indexed citations
2.
Kawakami, Takeshi, Toshihide Inui, Toshihiro Shiozawa, et al.. (2024). Patient Age andEGFR-positive Non-small Cell Lung Cancer: A Multicenter Retrospective Study. Anticancer Research. 44(4). 1751–1757.
3.
4.
Tamura, Tomohiro, Toshihiro Shiozawa, Hiroko Watanabe, et al.. (2023). Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI). Anticancer Research. 43(10). 4583–4591.
5.
Ohara, Gen, Toshihiro Shiozawa, Hiroko Watanabe, et al.. (2023). Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI). In Vivo. 37(5). 2203–2209.
6.
Yoneyama, Satoshi, et al.. (2022). Effect of Postoperative Muscle Loss After Resection of Non-small Cell Lung Cancer on Surgical Outcomes. Anticancer Research. 42(6). 3159–3168. 1 indexed citations
7.
Kanazu, Masaki, Mototsugu Shimokawa, Ryusei Saito, et al.. (2022). Predicting systemic therapy toxicity in older adult patients with advanced non-small cell lung cancer: A prospective multicenter study of National Hospital Organization in Japan. Journal of Geriatric Oncology. 13(8). 1216–1222. 4 indexed citations
8.
Yoneyama, Satoshi, Takeo Endo, Yukinori Inadome, et al.. (2018). Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes. Journal of Thoracic Oncology. 13(7). 895–903. 106 indexed citations
9.
Miyazaki, Kunihiko, Tomohiro Tamura, Takayuki Kaburagi, et al.. (2018). Real Clinical Practice of Using Afatinib Therapy in NSCLC Patients with an Acquired EGFR T790M Mutation. Anticancer Research. 38(9). 5409–5415. 5 indexed citations
10.
Endo, Takeo, et al.. (2017). Seasonal Influenza Vaccine-induced Pneumonitis Presenting with Multiple Pulmonary Nodules. Internal Medicine. 57(5). 707–711. 8 indexed citations
11.
Yahata, Yuichiro, Takeo Endo, Makoto Sonobe, et al.. (2016). A Epidemiological Investigation of a Nosocomial Outbreak of Multidrug-Resistant <i>Acinetobacter baumannii</i> in a Critical Care Center in Japan, 2011&ndash;2012. Japanese Journal of Infectious Diseases. 69(4). 356–356. 13 indexed citations
12.
Inagaki, Masaharu, Takayuki Kaburagi, Takeo Endo, et al.. (2016). S-1-containing chemotherapy for patients with non-small-cell lung cancer: A population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group. Molecular and Clinical Oncology. 4(6). 1025–1030. 2 indexed citations
13.
Yahata, Yuichiro, Takeo Endo, Makoto Sonobe, et al.. (2015). A Epidemiological Investigation of a Nosocomial Outbreak of Multidrug-Resistant <i>Acinetobacter baumannii</i> in a Critical Care Center in Japan, 2011&ndash;2012. Japanese Journal of Infectious Diseases. 69(2). 143–148. 14 indexed citations
14.
Mori, Kazuko, Takeo Endo, Haruo Ohtani, et al.. (2014). Epidermal Growth Factor Receptor Mutations: Effect on Volume Doubling Time of Non–Small-Cell Lung Cancer Patients. Journal of Thoracic Oncology. 9(9). 1340–1344. 25 indexed citations
15.
Konno, Satoshi, Nobuyuki Hizawa, Hironi Makita, et al.. (2014). The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma. Pharmacogenetics and Genomics. 24(5). 246–255. 6 indexed citations
16.
Kawaguchi, Tomoya, Masahiko Ando, Kazuhiro Asami, et al.. (2014). Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA). Journal of Clinical Oncology. 32(18). 1902–1908. 197 indexed citations
17.
Kikuchi, Norihiro, Akihiro Nomura, Takeo Endo, & Kiyohisa Sekizawa. (2006). Anaerobic bacterial empyema accompanying intrathoracic gas formation in anorexia nervosa. International Journal of Eating Disorders. 39(7). 621–623. 3 indexed citations
18.
Kiwamoto, Takumi, Takeo Endo, & Kiyohisa Sekizawa. (2004). [A case of septic pulmonary embolism induced by urinary tract infection].. PubMed. 42(1). 89–93. 1 indexed citations
19.
Nagasawa, Shigeru, et al.. (2002). Strategy of Control of Nosocomial Infections: Application of Disinfectants such as Povidone-Iodine. Dermatology. 204(Suppl. 1). 28–31. 3 indexed citations
20.
Endo, Takeo, et al.. (1999). [Miliary tuberculosis with atypical radiographic findings after aorto-coronary bypass surgery].. PubMed. 37(6). 499–503. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026